Could Discovery Regarding COVID-19 mRNA Vaccines Help Mesothelioma Patients?

Groundbreaking research published in the journal Nature has given rise to hope that mesothelioma patients could experience improved responses to immunotherapy treatment when combined with COVID-19 mRNA vaccines. A collaborative group of scientists from some of the world’s best cancer centers has found that SARS-CoV-2 vaccines sensitize immunologically “cold” tumors to immunotherapy and trigger powerful

Preclinical Study Shows Selective A2B Receptor Inhibitor Enhances Mesothelioma Immunotherapy

Researchers from Cyncado Therapeutics say that TT-4 monotherapy outperforms anti-PD-1 checkpoint inhibitors in treating mesothelioma, and that combining the two improves anti-tumor activity and increased T-cell infiltration even more. The group will be presenting details of its research at the upcoming AACR-NCI-EORTC International Conference to be held in Boston, Massachusetts, this coming weekend.

Connecticut Judge Increases Johnson & Johnson Mesothelioma Verdict to $25 Million 

A Connecticut judge has ordered consumer giant Johnson & Johnson to pay mesothelioma victim Evan Plotkin an additional $10 million in punitive damages. The ruling follows a jury awarding the real estate professional $15 million last October, bringing the total compensation to $25 million. Mr. Plotkin’s lawsuit claimed that decades of personal use of the

Clinical Trial Shows Promise for Mesothelioma Immunotherapy Protocol

Patients diagnosed with pleural mesothelioma face a challenging prognosis with limited options. But a groundbreaking study led by an international team of researchers is offering new hope. The group examined the use of immunotherapy both before and after surgery, and found that the protocol offered improved survival.   Clinical Trial Tests Immunotherapy in Operable Mesothelioma The

Researchers Report Promising Results from NERO Mesothelioma Study

According to clinical trial data presented at the American Association of Cancer Research (AACR) Annual Meeting in Chicago, a drug previously approved for the maintenance treatment of other recurrent cancers has reduced the risk of death or progression in patients with mesothelioma by 27%. The drug, Zejula (niraparib), is part of the NERO study being

Montana Mesothelioma Claimants Targeted by State House Proposed Bill

Hundreds of Libby, Montana, residents have been diagnosed with malignant mesothelioma, asbestosis, and other asbestos-related diseases in the years since the town was home to an infamous vermiculite mine. W.R. Grace & Co., BNSF Railroad, and others have been ordered to pay victims significant damages by juries who’ve heard of their negligence. Now, a series

Mesothelioma Victim’s Survivors Win Right to Have Case Heard Locally

When mesothelioma victims or their survivors pursue legal action against asbestos companies, they generally file their claims in local courts where the injury occurred. Many of these companies attempt to remove the action to federal court, especially if the claim has a link to a government contract. In a recently filed claim, the family of

Watervliet Arsenal and Asbestos Exposure

Located in Watervliet, New York, the Watervliet Arsenal is the nation’s oldest manufacturing arsenal. Founded more than 200 years ago to support military efforts during the War of 1812, it has operated ever since, manufacturing large caliber cannon tubes needed for tanks, artillery systems, and mortars. The facility has undergone multiple upgrades, renovations, and updates,

Asbestos Gaskets and Mesothelioma

Gaskets are mechanical seals that fit between two surfaces. Designed to prevent leakage under pressure, they have been used in applications ranging from car engines to heating systems and boilers. Though today’s gaskets are made from carbon-based or organic materials, for almost a century they were made from asbestos. Though asbestos gave gaskets strength and

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.